The North America stem cell market is evaluated to progress with a CAGR of 9.01% over the forecasting period of 2022 to 2030, capturing a revenue share of $11337.02 million by 2030.
NORTH AMERICA STEM CELL MARKET FORECAST 2022-2030
North America Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) Market by Product (Adult Stem Cell, Human Embryonic Stem Cell, Pluripotent, Mouse/Rat Neural) Market by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture) By Geography
The North America stem cell market is evaluated to progress with a CAGR of 9.01% over the forecasting period of 2022 to 2030, capturing a revenue share of $11337.02 million by 2030.
The increasing public-private funding and investments in stem cell-based research, technological advancements in stem cell manufacturing and preservation, and public awareness regarding the therapeutic potential of stem cell products are among the key factors attributed to the region’s market growth. However, the North America stem cell market may by hindered by unapproved stem cell interventions and regulatory issues linked to the therapeutic use of stem cells.
To know more about this report, request a free sample copy
The North America stem cell market growth assessment covers the analysis of the United States and Canada. The increasing expenditure on research and development in order to introduce novel stem cell therapies for rare and chronic conditions is projected to drive the stem cell market growth in the United States. Furthermore, the country also has an improved healthcare infrastructure compared to the majority of developed nations.
The United States has a higher number of products in the pipeline for stem cell therapies, as well. As the number of cancer cases continues to increase in the country, major players are also concentrating on R&D activities for the introduction of new stem cell therapies in the market. Moreover, the National Cancer Institute (NCI) stated that the United States’ expenditure on cancer care is anticipated to reach $156 billion by 2020, and this factor is set to bolster the stem cell market’s growth over the upcoming years.
Canada is one of the leading nations in the field of stem cell research. Aligning with this, the country’s researchers have introduced stem cell therapy in the healthcare industry, as well, thus saving numerous lives. According to the Heart and Stroke Foundation, around nine in ten Canadians have at least one risk factor linked to heart disease and strokes. The high prevalence rate of cardiac ailments offers significant opportunities for the development of new and effective stem cell therapies. As a result, these factors are anticipated to augment the stem cell market growth in North America during the forecast years.
The North America stem cell market is segmented into therapeutic application, product, technology, application, and treatment type. The therapeutic application segment includes orthopedic treatments, injuries and wounds, oncology disorders, cardiovascular disorders, neurological disorders, diabetes, and other therapeutic applications. The clinical application of mesenchymal stem cells in the field of orthopedics primarily helps treat degenerative osteoarthritis. Furthermore, the increasing focus on stem cell therapy for orthopedic surgery is ascribed to faster healing capabilities, safe procedures, lower risk of complications, and infection prevention.
On the other hand, stem cells have evolved as a promising therapy for wounds owing to their unique self-renewal as well as differentiation properties. Moreover, stem cell therapy may also become a first-line therapeutic choice for treating non-healing chronic wounds.
Some of the top players operating in the North America stem cell market are GE Healthcare, AllCells LLC, etc.
GE Healthcare, headquartered in the United States, is a business segment of General Electric. The company is one of the leading providers of medical technologies as well as related services. It offers biopharmaceutical manufacturing technologies, medical diagnostics, performance improvement, patient monitoring systems, performance solutions, and others.
Report Synopsis
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Therapeutic Application, Product, Technology, Application, Treatment Type |
| Countries Analyzed | The United States and Canada |
| Companies Analyzed | AllCells LLC, Becton, Dickinson and Company, Corning Inc, Lorem Cytori Inc, GE Healthcare, International Stem Cell Corporation (ISCO), Merck KGaA (Sigma Aldrich), Miltenyi Biotec, Pluri Inc, Qiagen, Smith+Nephew PLC, Stemcell Technologies Inc, Stryker Corporation, Takara Holdings Inc, Thermo Fisher Scientific Inc |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- SURGING DEMAND FOR STEM CELLS IN REGENERATIVE MEDICINE
- GROWING R&D INVESTMENTS IN STEM CELL THERAPIES & RESEARCH
- RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
- REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
- KEY RESTRAINTS
- ABSENCE OF A WELL-DEFINED REGULATORY FRAMEWORK FOR STEM CELL THERAPY
- HIGH COSTS ASSOCIATED WITH STEM CELL PROCEDURES
- ETHICAL ISSUES AND SOCIAL COMPLEXITIES
- LESS RESPONSIVENESS IN DEVELOPED ECONOMIES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON STEM CELL MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- PRICE
- EFFICACY
- APPLICATION AND EFFECTIVENESS
- ACCURACY
- REGULATORY FRAMEWORK
- MARKET BY THERAPEUTIC APPLICATION
- ORTHOPEDIC TREATMENTS
- INJURIES & WOUNDS
- ONCOLOGY DISORDERS
- CARDIOVASCULAR DISORDERS
- NEUROLOGICAL DISORDERS
- DIABETES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCT
- ADULT STEM CELL
- HEMATOPOIETIC STEM CELL
- NEURAL STEM CELL
- UMBILICAL CORD STEM CELL
- MESENCHYMAL STEM CELL
- DENTAL STEM CELL
- HUMAN EMBRYONIC STEM CELL
- PLURIPOTENT
- MOUSE/RAT NEURAL
- ADULT STEM CELL
- MARKET BY TECHNOLOGY
- CELL ACQUISITION
- BONE MARROW HARVEST
- UMBILICAL CORD
- APHERESIS
- CELL PRODUCTION
- THERAPEUTIC CLONING
- IN VITRO FERTILIZATION (IVF)
- CELL CULTURE
- ISOLATION
- CRYOPRESERVATION
- EXPANSION & SUB-CULTURE
- CELL ACQUISITION
- MARKET BY APPLICATION
- REGENERATIVE MEDICINE
- DRUG DISCOVERY AND DEVELOPMENT
- MARKET BY TREATMENT TYPE
- ALLOGENEIC STEM CELL THERAPY
- AUTOLOGIC STEM CELL THERAPY
- SYNGENEIC STEM CELL THERAPY
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PARTNERSHIPS
- COMPANY PROFILES
- ALLCELLS LLC
- BECTON, DICKINSON AND COMPANY (BD)
- CORNING INC
- GE HEALTHCARE
- INTERNATIONAL STEM CELL CORPORATION
- LOREM CYTORI INC
- MERCK KGAA (SIGMA ALDRICH)
- MILTENYI BIOTEC
- PLURI INC
- QIAGEN
- SMITH+NEPHEW PLC
- STEMCELL TECHNOLOGIES INC
- STRYKER CORPORATION
- TAKARA HOLDINGS INC
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: NORTH AMERICA MARKET SNAPSHOT – STEM CELL
TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: NORTH AMERICA STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: NORTH AMERICA STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: NORTH AMERICA STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: NORTH AMERICA STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: NORTH AMERICA STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: NORTH AMERICA STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET
TABLE 23: LIST OF ACQUISITIONS
TABLE 24: LIST OF PARTNERSHIPS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021
FIGURE 9: NORTH AMERICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA STEM CELL MARKET, BY DIABETES, 2022-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 17: NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021
FIGURE 19: NORTH AMERICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 20: NORTH AMERICA STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: NORTH AMERICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 25: NORTH AMERICA STEM CELL MARKET, BY PLURIPOTENT, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 28: NORTH AMERICA STEM CELL MARKET, BY CELL ACQUISITION, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021
FIGURE 30: NORTH AMERICA STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2030 (IN $ MILLION)
FIGURE 31: NORTH AMERICA STEM CELL MARKET, BY UMBILICAL CORD, 2022-2030 (IN $ MILLION)
FIGURE 32: NORTH AMERICA STEM CELL MARKET, BY APHERESIS, 2022-2030 (IN $ MILLION)
FIGURE 33: NORTH AMERICA STEM CELL MARKET, BY CELL PRODUCTION, 2022-2030 (IN $ MILLION)
FIGURE 34: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021
FIGURE 35: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2030 (IN $ MILLION)
FIGURE 36: NORTH AMERICA STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2030 (IN $ MILLION)
FIGURE 37: NORTH AMERICA STEM CELL MARKET, BY CELL CULTURE, 2022-2030 (IN $ MILLION)
FIGURE 38: NORTH AMERICA STEM CELL MARKET, BY ISOLATION, 2022-2030 (IN $ MILLION)
FIGURE 39: NORTH AMERICA STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2030 (IN $ MILLION)
FIGURE 40: NORTH AMERICA STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2030 (IN $ MILLION)
FIGURE 41: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 42: NORTH AMERICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)
FIGURE 43: NORTH AMERICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2030 (IN $ MILLION)
FIGURE 44: NORTH AMERICA STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021
FIGURE 45: NORTH AMERICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 46: NORTH AMERICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 47: NORTH AMERICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 48: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 49: UNITED STATES STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: CANADA STEM CELL MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY THERAPEUTIC APPLICATION
- ORTHOPEDIC TREATMENTS
- INJURIES & WOUNDS
- ONCOLOGY DISORDERS
- CARDIOVASCULAR DISORDERS
- NEUROLOGICAL DISORDERS
- DIABETES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCT
- ADULT STEM CELL
- HEMATOPOIETIC STEM CELL
- NEURAL STEM CELL
- UMBILICAL CORD STEM CELL
- MESENCHYMAL STEM CELL
- DENTAL STEM CELL
- HUMAN EMBRYONIC STEM CELL
- PLURIPOTENT
- MOUSE/RAT NEURAL
- ADULT STEM CELL
- MARKET BY TECHNOLOGY
- CELL ACQUISITION
- BONE MARROW HARVEST
- UMBILICAL CORD
- APHERESIS
- CELL PRODUCTION
- THERAPEUTIC CLONING
- IN VITRO FERTILIZATION (IVF)
- CELL CULTURE
- ISOLATION
- CRYOPRESERVATION
- EXPANSION & SUB-CULTURE
- CELL ACQUISITION
- MARKET BY APPLICATION
- REGENERATIVE MEDICINE
- DRUG DISCOVERY AND DEVELOPMENT
- MARKET BY TREATMENT TYPE
- ALLOGENEIC STEM CELL THERAPY
- AUTOLOGIC STEM CELL THERAPY
- SYNGENEIC STEM CELL THERAPY
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.